Literature DB >> 9599238

Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.

S Gagliardi1, P A Gatti, P Belfiore, A Zocchetti, G D Clarke, C Farina.   

Abstract

The macrolide antibiotic bafilomycin A1 is a highly potent and selective inhibitor of all the vacuolar ATPases (V-ATPases). With the aim of obtaining novel analogues specific for the osteoclast subclass of vacuolar ATPase, 31 derivatives of bafilomycin A1 were synthesized and tested for their ability to inhibit differentially the V-ATPase-driven proton transport in membrane vesicles derived from chicken osteoclasts (cOc) and bovine chromaffin granules (bCG). Although none of the new analogues were more potent than the parent compound, the obtained data provided a significant amount of information about the structural requirements for the inhibitory activity of bafilomycin A1. The different effects of a few analogues on the two enzymes could also suggest the possibility of a selective modulation of the V-ATPases in different tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9599238     DOI: 10.1021/jm9707838

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.

Authors:  Behzad Yeganeh; Saeid Ghavami; Andrea L Kroeker; Thomas H Mahood; Gerald L Stelmack; Thomas Klonisch; Kevin M Coombs; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.

Authors:  Christin Osteresch; Tobias Bender; Stephanie Grond; Paultheo von Zezschwitz; Brigitte Kunze; Rolf Jansen; Markus Huss; Helmut Wieczorek
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

3.  Complete elucidation of the late steps of bafilomycin biosynthesis in Streptomyces lohii.

Authors:  Zhong Li; Lei Du; Wei Zhang; Xingwang Zhang; Yuanyuan Jiang; Kun Liu; Ping Men; Huifang Xu; Jeffrey L Fortman; David H Sherman; Bing Yu; Song Gao; Shengying Li
Journal:  J Biol Chem       Date:  2017-03-14       Impact factor: 5.157

4.  Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.

Authors:  Huan Meng; Min Xue; Tian Xia; Yan-Li Zhao; Fuyuhiko Tamanoi; J Fraser Stoddart; Jeffrey I Zink; Andre E Nel
Journal:  J Am Chem Soc       Date:  2010-09-15       Impact factor: 15.419

5.  A small GTPase, human Rab32, is required for the formation of autophagic vacuoles under basal conditions.

Authors:  Yuko Hirota; Yoshitaka Tanaka
Journal:  Cell Mol Life Sci       Date:  2009-07-11       Impact factor: 9.261

6.  A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.

Authors:  Kazuaki Niikura; Mikiko Takano; Masae Sawada
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

7.  Efficient Preparation of Bafilomycin A1 from Marine Streptomyces lohii Fermentation Using Three-Phase Extraction and High-Speed Counter-Current Chromatography.

Authors:  Ye Yuan; Xiaoping He; Tingting Wang; Xingwang Zhang; Zhong Li; Xiaoqing Xu; Weiyan Zhang; Xiaojun Yan; Shengying Li; Shan He
Journal:  Mar Drugs       Date:  2020-06-25       Impact factor: 5.118

8.  Engineering Bafilomycin High-Producers by Manipulating Regulatory and Biosynthetic Genes in the Marine Bacterium Streptomyces lohii.

Authors:  Zhong Li; Shuai Li; Lei Du; Xingwang Zhang; Yuanyuan Jiang; Wenhua Liu; Wei Zhang; Shengying Li
Journal:  Mar Drugs       Date:  2021-01-11       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.